Ablynx Is Awarded Eur 1.9 Million Grant To Explore New Therapeutic Uses Of Nanobodies(R)
GHENT, BELGIUM--(MARKET WIRE)--Sep 25, 2007 -- Ablynx the biopharmaceutical company focused on the discovery and development of Nanobodies®, today announced that it has been awarded a grant worth EUR 1.855M by the Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT).